These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 8489292)

  • 1. [Influences of 5'-deoxy-5-fluorouridine (5'-DFUR) on cell cycle in patients with breast cancer].
    Kimura T; Muraki H; Kamio T; Katoh T; Fujii A; Yamamoto K; Hamano K
    Gan To Kagaku Ryoho; 1993 Apr; 20(6):816-20. PubMed ID: 8489292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Significance of 5'-deoxy-5-fluorouridine (5'-DFUR) administration before surgery for advanced gastric and colonic cancers--activity of pyrimidine nucleoside phosphorylase (PyNPase) and serum immunosuppressive acidic protein (IAP)].
    Murakami N; Hirano M; Saito H; Nagao S; Arano Y; Kikuchi T; Ishikawa N; Kurokawa M; Kitsukawa H
    Gan To Kagaku Ryoho; 1996 Dec; 23(14):1959-66. PubMed ID: 8978804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Correlation between pyrimidine nucleoside phosphorylase (PyNPase)/thymidine phosphorylase/platelet-derived endothelial cell growth factor and histological prognostic factor, and influence of 5'-deoxy-5-fluorouridine (5'-DFUR) administration on PyNPase activities and serum immunosuppressive acidic protein levels. A study group of oral anti-cancer drugs in Seiban/Tajima area].
    Satoh B; Ohtoshi M; Ishida Y; Hen-mi K; Kaneko I; Soda M; Sugihara J; Shibagaki F; Iwai N; Nakamura T; Yamasaki T; Matsumoto S
    Gan To Kagaku Ryoho; 1998 Feb; 25(3):359-64. PubMed ID: 9492829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Correlation between pyrimidine nucleoside phosphorylase (PyNPase)/platelet-derived endothelial cell growth factor and histological prognostic factor, and influences of 5'-deoxy-5-fluorouridine (5'-DFUR) administration on PyNPase levels. 5'-DFUR Joint Research Group in the Osaka Area for Gastric Cancer].
    Yamasaki Y; Kuwata K; Hioki K; Sowa M; Hirakawa K; Okajima K; Isozaki H; Iwanaga T; Furukawa H; Nakano H; Watanabe A; Takami M; Tsukahara Y; Matsunaga S; Kikkawa N; Gotoh T; Tokuda H; Takahashi S; Toyohara M; Yagi M; Takebayashi J; Nakajima T; Miyazaki H; Kuwata H; Nakazato H
    Gan To Kagaku Ryoho; 1998 Aug; 25(10):1549-56. PubMed ID: 9725048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Usefulness of low dose 5'-DFUR (5'-deoxy-5-fluorouridine) for advanced or recurrent breast cancer].
    Sonoo H; Senoo T; Nishiki M; Morimoto T; Takashima S
    Gan To Kagaku Ryoho; 1999 Jun; 26(7):951-8. PubMed ID: 10396323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The alteration of PyNPase activity in breast cancers due to preoperative oral administration of 5'-DFUR].
    Akao S; Yoshida M; Abe S; Kojima M; Ishikawa H; Soma R
    Gan To Kagaku Ryoho; 1997 Apr; 24(6):685-90. PubMed ID: 9126305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antitumor effect of 5'-DFUR and PyNPase activity in colorectal cancer].
    Honda M; Tanaka Y; Matsuo Y; Yamamoto S; Hazama K; Inoue Y; Takao T; Fushimi H
    Gan To Kagaku Ryoho; 1999 Jun; 26(7):939-43. PubMed ID: 10396321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of preoperative oral 5'-DFUR on PyNPase level in gastrointestinal malignant tumor tissues].
    Wang WJ; Shi D; Wang SM
    Ai Zheng; 2003 Jun; 22(6):653-7. PubMed ID: 12948420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of 5-deoxy-5-fluorouridine and tamoxifen show cell-type specific antagonistic and cooperative effects on cytotoxicity in human mammary carcinoma cells.
    Bollig A; Du QQ; Fan ST; Yu B; Sarkar FH; Liao J
    Oncol Rep; 2005 Jul; 14(1):177-83. PubMed ID: 15944786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of 5'-DFUR and lentinan on cytokines and PyNPase against AH66 ascites hepatoma in rats.
    Ogawa T; Ohwada S; Sato Y; Izumi M; Nakamura S; Takeyoshi I; Kawashima Y; Ohya T; Koyama T; Morishita Y
    Anticancer Res; 1999; 19(1A):375-9. PubMed ID: 10226570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect on 5'-deoxy-5-fluorouridine (5'-DFUR) of pyrimidine nucleoside phosphorylase (PyNPase), matrix metalloprotease and serum IAP values. Hokuriku Colorectal Cancer Chemotherapy Study Group].
    Nishimura G; Izumi R; Matsuki N; Takeyama S; Konishi K; Fujita H; Miyata R; Sasaki T; Kojima Y; Takada M; Takita Y; Kanno M; Ueno K; Mura T; Asano K; Syouji M; Yamazaki H; Ooto T; Ueda H; Takigawa Y; Sawa T; Miyazaki I
    Gan To Kagaku Ryoho; 1997 Oct; 24(13):1947-52. PubMed ID: 9350241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between clinicopathological factors and the reduction of pyrimidine nucleoside phosphorylase activity after preoperative administration of 5'-deoxy-5-fluorouridine.
    Honda T; Inagawa H; Nishizawa T; Yoshimura H; Yamamoto I; Soma G
    Anticancer Res; 2010 Aug; 30(8):3207-11. PubMed ID: 20871042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of 5'-deoxy-5-fluorouridine (5'-DFUR) on the activity of pyrimidine nucleoside phosphorylase (pyNPase) in normal and tumor tissues of human stomach].
    Kimura T; Kobayashi T; Nakaya Y; Iida T; Uchimura M; Murohisa B; Nagashima T; Matsumoto Y; Kitamura H; Shibata M
    Gan To Kagaku Ryoho; 1995 Jul; 22(8):1051-6. PubMed ID: 7611757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A new anticancer drug, 5'-deoxy-5-fluorouridine (5'-DFUR)].
    Tsukagoshi S
    Gan To Kagaku Ryoho; 1987 Oct; 14(10):2977-82. PubMed ID: 2959207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [PyNPase and DPD expression potentially predict response to 5'-DFUR treatment for node-positive breast cancer patients].
    Akao S; Inoue K
    Gan To Kagaku Ryoho; 2003 Sep; 30(9):1361-4. PubMed ID: 14518422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A study on pre-operative administration of 5'-DFUR in carcinomas of the gastric, breast, thyroid and colon].
    Munemoto Y; Omura K; Hikishima H; Okada Y; Hayashi H; Adachi I; Douden K; Watanabe Y; Iwa T
    Gan To Kagaku Ryoho; 1990 Dec; 17(12):2415-20. PubMed ID: 2148066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumor activity of 5'-deoxy-5-fluorouridine in human digestive organ cancer xenografts and pyrimidine nucleoside phosphorylase activity in normal and neoplastic tissues from human digestive organs.
    Nio Y; Kimura H; Tsubono M; Tseng CC; Kawabata K; Masai Y; Hayashi H; Meyer C; Fukumoto M; Tobe T
    Anticancer Res; 1992; 12(4):1141-6. PubMed ID: 1386969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of EGFR phosphorylation in a panel of human breast cancer cells correlates with synergistic interactions between gefitinib and 5'-DFUR, the bioactive metabolite of Xeloda.
    Ait-Tihyaty M; Rachid Z; Mihalcioiu C; Jean-Claude BJ
    Breast Cancer Res Treat; 2012 May; 133(1):217-26. PubMed ID: 21915635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Long-term outcome of preoperative chemotherapy with 5'-deoxy-5-fluorouridine (5'-DFUR) for gastric cancer].
    Kobayashi T; Kimura T
    Gan To Kagaku Ryoho; 2000 Sep; 27(10):1521-6. PubMed ID: 11015996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [5'-DFUR chemoprophylaxis in superficial bladder cancer. Kanagawa Urology 5'-DFUR Study Group].
    Kubota Y; Noguchi S; Masuda M; Hosaka M; Noguchi K; Sasaki K; Miura T; Ikeda I; Kondo I; Senga Y; Moriyama M; Fukushima S; Ebato T; Fukuda M; Kitami K; Fukuoka H; Sato K; Hirokawa M; Chiba K; Kanno H; Miyai K
    Hinyokika Kiyo; 2000 Aug; 46(8):525-30. PubMed ID: 11019370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.